- In recent weeks, Madison Small Cap Fund highlighted Leonardo DRS in its Q1 2026 investor letter after the company delivered better than expected results, helped by its electronic propulsion system on the Columbia-class submarine platform and exposure to the Golden Dome missile defense initiative.
- At the same time, insider share sales and ongoing benefits from the US Department of War’s move away from larger prime contractors have drawn attention to how Leonardo DRS’s mix of long-term contracts and emerging defense programs could reshape its risk and opportunity profile.
- We’ll now examine how Leonardo DRS’s role in programs like Golden Dome may influence its investment narrative and future growth assumptions.
The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
Leonardo DRS Investment Narrative Recap
To own Leonardo DRS, you need to believe in steady demand for advanced sensing, naval power systems, and missile defense programs such as Golden Dome, supported by long term U.S. government contracts. The recent highlight from Madison Small Cap Fund and better than expected results reinforce the near term catalyst around missile defense and Columbia class propulsion exposure, while the pattern of insider selling sharpens the main risk that high expectations and contract concentration may already be reflected in the share price.
Among recent announcements, the multiple contracts under the Missile Defense Agency’s SHIELD program, with a ceiling value of US$151 billion, tie directly into the same missile defense theme as Golden Dome. These awards sit squarely in the current catalyst of growing demand for advanced missile detection and tracking, but they also increase exposure to the key risk that any future shift in U.S. defense priorities or budget timing could have an outsized effect on Leonardo DRS’s revenue visibility.
Yet beneath the strong contract wins, investors should still weigh how insider selling and concentrated U.S. defense exposure could affect...
Read the full narrative on Leonardo DRS (it's free!)
Leonardo DRS' narrative projects $4.5 billion revenue and $433.1 million earnings by 2029. This requires 7.1% yearly revenue growth and about $143.1 million earnings increase from $290.0 million today.
Uncover how Leonardo DRS' forecasts yield a $52.90 fair value, a 9% upside to its current price.
Exploring Other Perspectives
Some of the lowest ranked analysts were expecting revenue to reach about US$4.4 billion and earnings around US$531.6 million by 2029, which is far more cautious than the consensus and highlights how much opinions can differ on risks like defense budget pressure and valuation, especially now that fresh news on programs such as Golden Dome could shift those expectations in either direction.
Explore 5 other fair value estimates on Leonardo DRS - why the stock might be worth as much as 22% more than the current price!
Form Your Own Verdict
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Leonardo DRS research is our analysis highlighting 2 key rewards that could impact your investment decision.
- Our free Leonardo DRS research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Leonardo DRS' overall financial health at a glance.
Want Some Alternatives?
Opportunities like this don't last. These are today's most promising picks. Check them out now:
- Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.
- AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- Uncover the next big thing with 24 elite penny stocks that balance risk and reward.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com